The method of treatment of vibration disease

 

(57) Abstract:

Usage: medicine, occupational diseases, treatment of vibration disease from exposure to local vibration. Goal: improving efficiency and reducing treatment time of vibration disease. The inventive implementation of a complex drug therapy and the effect of direct electric current on the wrists of the patient. The new method is that first intravenously slowly introducing the mixture of novocaine, Karandila, papaverine, Dimedrol, and nicotinic acid dose, starting with half and gradually increasing to the maximum. At the same time, after injection daily galvanizing both hands for 25-30 min, treatment 6-10 days. 1 C.p. f-crystals.

The invention relates to medicine, namely to the pathology, and can be used for treatment of vibration disease (WB), especially from the effects of local vibration.

There is a method of treatment of vibration disease through the course of electrophoresis with a 5% solution of novocaine at the hands of the patient and administration of complex drug Guide for occupational diseases, edited by Acad. Izmerov N. F. M. Medicine, so 2 1983 C. 15 is, microcirculation, amiodaronesee and innervation lesions characteristic of the WB, as well as the duration of treatment (22-24 days) and the frequency of treatment 2 times a year.

The invention is directed to solution of the problem: improving efficiency and reducing treatment time of vibration disease.

This task is achieved through a complex of drug therapy and the effects of direct current on both hands of the patient.

The new method is that first intravenously slowly (in same syringe) introducing the mixture of novocaine, Karandila, papaverine, Dimedrol, and nicotinic acid dose, starting with half and gradually increasing it to the maximum. At the same time, after injection daily galvanizing both hands for 25 to 30 minutes, 6 to 10 days.

The use of a mixture of five drugs can increase the effectiveness of treatment due to the complex influence on the pathogenetic mechanism WB.

DC has expressed misleading and cumulicola ability, allowing injected into the blood of the patient vasodilator mixture of drugs quickly and deeply about the Oka stay of the patient in the hospital.

The method is as follows.

A patient is injected in the same syringe vasodilator mixture consisting of 1 ml of 0.5% solution of Karandila, 1 ml of 2% R-RA papaverine, 0.5 ml of 1% R-RA Dimedrol, 2 ml of 1% R-RA nicotinic acid and 15 ml of 0.25 R-RA novocaine. Immediately after the injection the patient conduct cross-galvanizing both hands with amperage 6 12 mA, duration of exposure 25 to 30 minutes, daily for 6-10 days. Dose of salts of the mixture gradually increased and cook for 4 to 5 a day up to a maximum: 2 ml of 0.5% R-RA curantyl, 2 ml of 2% R-RA papaverine, up to 1 ml 1% R-RA Dimedrol, 4 ml of 1% R-RA nicotinic acid and 11 ml of 0.25% R-RA novocaine. The treatment is accompanied by the ingestion of multivitamins.

Example 1.

Patient S. 39 years was admitted to the hospital the city center, Perm, diagnosed with WB 1 degree, peripheral amiodaronesee syndrome, vegetariana polyneuropathy of upper extremities. The patient was injected intravenously in the same syringe vasodilator mixture consisting of half doses of Karandila, papaverine, Dimedrol, nicotinic acid and novocaine, and then conducted cross-galvanizing both hands for 25 min daily for 6 days with the power tomaximise. In addition, the patient was administered inside a multivitamin. The patient was discharged on the 10th day in a satisfactory condition. It was noted the disappearance of pain, numbness, coldness, sweating hands, improvement of General condition, sleep, as well as thermal and reovazograficheskie indicators, the positive dynamics of traditional samples at WB.

Example 2.

Patient, 48 years of age was admitted to the hospital of the city center with a diagnosis of WB 2nd degree, peripheral amiodaronesee syndrome with frequent angiospazmam fingers. Autonomic - sensory polyneuropathy with vegetative trophic disorders in the hands. The patient was injected intravenously slowly vasodilator mixture consisting of half doses of Karandila, papaverine, Dimedrol, nicotinic acid, the rest R-R novocaine, and then conducted cross-galvanizing both hands daily for 30 min with amperage 10-12 mA, the course of 10 days. Dose of salts of the mixture gradually increased and brought on the 4th day to the maximum accepted: 2 ml of 0.5% R-RA curantyl, 4 ml of 1% R-RA nicotinic acid, 2 ml of 2% R-RA papaverine, up to 1 ml 1% R-RA Dimedrol, 11 ml of 0.25% R-RA novocaine. In addition, the patient is injected with a vitamin b5and aloe. On the 12th day of the patient wypi, chilliness, perspiration hands, improved thermographic picture of the hands and the indices of the blood supply to distal hand and vascular tone, positive dynamics of indicators of traditional samples at WB.

The positive effect from the use of the proposed method of treatment WB is the following: increasing the effectiveness of treatment, prolonging remission (when the WB 1,2-stage up to 1 year instead of 6 months with conventional treatment); the reduction of treatment time and patient stay in the hospital 2 times; the routine maintenance course at the time of recovery (sanatorium preventorium).

1. The method of treatment of vibration disease by conducting complex medical therapy and the impact of a constant electric current at the hands of the patient, characterized in that initially intravenously slowly introducing the mixture of novocaine, Karandila, papaverine, Dimedrol, and nicotinic acid, immediately after the injection cross galvanizing of hands for 25 to 30 minutes daily for 6 to 10 days.

2. The method according to p. 1, characterized in that the introduction of a mixture of products is carried out, gradually increasing the dose to half-time to the maximum.

 

Same patents:

The invention relates to the field of agriculture, division of animal health, and in particular to methods and devices for electrical stimulation of the muscles of the abdomen and uterus in animals with pathological childbirth (weak contractions and attempts, retention of placenta)
The invention relates to medicine, namely to Pediatrics, and can be used in the treatment of chronic gastroduodenitis in children

The invention relates to medicine, namely to dermatology, and can be used in the treatment of allergic
The invention relates to medicine, namely to therapy, and can be used in the treatment of various diseases by electric shocks on biologically active points

The invention relates to medicine, namely to reflexology and can be used to maintain the health of drivers

The invention relates to trauma and can be used to construct devices and devices for fixing the damaged bone tissue, with their injuries
The invention relates to medicine, namely to dentistry
The invention relates to medicine, namely to traumatology and orthopedics, neurology and neurosurgery, and can be used in the treatment of complicated forms of osteochondrosis by physiotherapy, as well as a secondary impact after surgery on the spine, spinal cord and its entities

The invention relates to medicine, namely, neurology, and can be used in the treatment of polyneuropathy

The invention relates to medicine, in particular to surgical gastroenterology and neurology, as well as tools for electrical effects on organs and tissues, and can be used for long-term drug infiltration of the celiac plexus with local monoelectronic

FIELD: medicine.

SUBSTANCE: method involves carrying out transcranial micro polarizations once a week during 4-6 weeks in 15-20 min long sessions with 80-200 mcA large current over 2 electrodes. Anode is applied to the boundary of posterior region of superior temporal convolution and inferior parietal zone of the left hemisphere. The electrode is applied in later sessions to the boundary of inferior frontal region and anterior regions of superior temporal convolution and to projection of motor area of the left hemisphere cortex. The cathode is applied to the inferior regions of the left occipital area. Logopedic lessons are combined with psychological training during and between the transcranial micro polarization sessions. The treatment course is repeated when needed not more than 2-3 times a year.

EFFECT: enhanced effectiveness of treatment.

FIELD: medicine, neurology, reflexotherapy.

SUBSTANCE: the method deals with affecting biologically active points out of the following row: VB44, TR1, TR17, TR23, E1, GI20, E7, E6, E2, CI19, E4. Then comes pharmacopuncture due to applying the solution of hydrocortisone succinate. Impact should be performed with direct current through needles introduced into biologically active points.

EFFECT: shortened terms of therapy.

1 ex

FIELD: medicine, surgery, surgical hepatology, intervention radiation diagnostics.

SUBSTANCE: due to ultrasound control one should introduce monopolar electrodes being parallel to the direction of vessels. Moreover, a cathode is being at the distance of 10 mm against vascular wall. Then comes electrochemical lysis (ECL) for 20 min, not more after the contact of echo-positive formation appeared during the lysis with vascular wall at the distance for not less than 1.3 against metastase diameter. The innovation enables to carry out efficient metastatic lysis near large hepatic vessels at no risk of hemorrhagic growth due to US-criteria of tissue lysis sufficiency being near the vessel without any disorders in muscular layers of vascular wall.

EFFECT: higher efficiency of therapy.

2 dwg, 1 ex

FIELD: physiotherapy and health resort treatment.

SUBSTANCE: before treatment, condition of vegetative nervous system is examined and, when initial vegetative tonus is regarded as sympathicotonia and hypersympathicotonia, galvanization of collar region according to Shcherbak and common-use pearl bathes are recommended. When initial vegetative tonus is regarded as vagotonia, microwave therapy and common-use radon bathes are recommended.

EFFECT: increased treatment efficiency due to improved vegetative nervous system condition as well as general hemodynamic and biochemical and hormonal investigation characteristics.

5 cl, 7 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: method involves applying combined trans-spinal micro-polarization and pulsed stimulation. The trans-spinal micro-polarization is carried out using constant current of 100-300 mcA by applying skin electrodes of 20-35 cm large area. The trans-spinal micro-polarization is carried out during 30-40 min. Anode is placed lateral with respect to spinal process of the seventh vertebra C7 and cathode is placed contralaterally with respect to the anode in lumbosacral zone at the level of spinal processes of L5-S1. Magnetic pulsed stimulation is carried out with short pulses having two in every emitted package. Magnetic induction amplitude of the first pulse is equal to 1400 mTesla units and of the second one is less by 55%. The pulses are sent along the right and left side of the vertebral column in turn giving 3-4 packages per each spine segment. Stimulation is started beginning from cervical segment. The total treatment course is 6-7 procedures long with pauses being not longer than 2 days.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves treating immunocompetent organ regions with low frequency electric current for instance in animal groups like rats during 2 weeks. Drug-induced immunodeficiency is modeled in the animals 2 days later, after the treatment course is over, by intraperitoneally introducing 2% cyclophosphan solution once per 3 days (the total preparation dose is equal to 42 mg). Spleen and thymus mass, antibody-forming cells quantity in spleen and phagocytic activity of leukocytes are determined. Prophylactic action of factor of physical nature is evaluated by calculating prophylaxis index by dividing product of spleen mass, antibody-forming cells and phagocytic activity of leukocytes per thymus mass. The result is to be divided by 103. The prophylaxis index value exceeding 8.0, prophylaxis effectiveness is considered to be available.

EFFECT: high accuracy of estimates.

FIELD: medicine, neurology, physiotherapy.

SUBSTANCE: contact action by electric current on the region of the forehead and mastoid processes and contact action by magnetic field along the vertebral column are performed simultaneously. The action on the region of the forehead and mastoid processes is effected by direct current, 1 to 7 mA strong, modulated by low-frequency square pulses. A frequency within 0.5 to 550 Hz causing a change of the electrodermal resistance in the biologically active points is assigned as operating frequency. Action along the vertebras is effected by a pulse field with amplitude of magnetic induction up to 1 T and pulse frequency up to 100 Hz. The dominant frequency by the results of the electroencephalography is assigned as operating frequency, and the time of action is set to be equal to 35+-5 min. The device has an electrostimulator unit, whose output is made for connection to the electrodes in the patient's circuit, and a magnetic field forming unit with a solenoid, with a magnetic field forming unit with a solenoid, with power units each. The electrostimulator unit has a transducer of a series-connected master oscillator, transformer-coupled amplifier and a rectifier. The rectifier output is connected to the input of the first gate and made as the output of the electrostimulator unit. The device has a pulse shaper, whose output is connected to the input of the first gate, an output current level controller made for starting from the master oscillator, and whose output via the second gate and a ripple filter is connected to the transformer-coupled amplifier and the adder. The adder output is connected to the output of the first gate and the current meter. The magnetic field forming unit has a capacitor connected to the solenoid winding and via the switching unit - to the power unit. The switching unit is connected to the output of the control unit. The input of the pulse shaper of the electrostimulator unit and the input of the control unit of the magnetic field forming unit are made for connection to a personal computer via galvanic isolators.

EFFECT: reduced degree of disintegration in the structures of the limbic-reticular complex producing an optimizing action on the neurodynamics.

3 cl, 5 ex, 2 dwg

FIELD: medicine, reflexotherapy.

SUBSTANCE: one should match biologically active points and with subsequent impact upon them. One should choose biologically active point that corresponds to an organ with pathological cell proliferation. Then on should measure the potential of chosen biologically active point against a reference point. Then it is necessary to switch on the external source of direct electric field to chosen points. The poles of this source should be opposite by sign to those of points, and its absolute value is equal to the difference of absolute values of measured potential and a potential corresponding to healthy organ in chosen point. The impact should be performed up to the value of membranous potential of cancer cell being equal to the value of membranous potential of corresponding healthy organ. The innovation suggested simplifies therapeutic technique.

EFFECT: higher efficiency of therapy.

FIELD: medicine, gynecology.

SUBSTANCE: one should carry out galvanization during 15 min due to applying electrodes along abdominal-sacral technique. Just before galvanization one should introduce 15 ml 2%-chitosan ascorbate gel containing metronidasol at the dosage of 2 mg/ml gel, intravaginally at 36-38° C. Procedures should be carried out once daily, therapy course lasts for about 7-8 d. The innovation suggested provides total curative effect of antibacterial remedies and galvanization at decreased dosage of metronidasol and, thus, enables to obtain stable remission of salpingo-oophoritis.

EFFECT: higher efficiency of therapy.

1 ex, 1 tbl

FIELD: medicine, gynecology, immunology.

SUBSTANCE: for microenemas carried out just before galvanization according to abdominal-sacral technique one should apply 1%-chitosan ascorbate gel at the quantity of 20 ml, at temperature of 36-38° C, once daily, about 8-9 procedures/course. The present innovation enables to decrease inflammatory conglomerate and prevent massive adhesion-formation due to creating rectal enterosorbent depot that enables to enhance the sorption of toxic products through rectal wall out of inflammation focus.

EFFECT: higher efficiency of therapy.

1 ex, 3 tbl

Up!